Ofloxacin
"Ofloxacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
Descriptor ID |
D015242
|
MeSH Number(s) |
D03.633.100.810.835.322.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ofloxacin".
Below are MeSH descriptors whose meaning is more specific than "Ofloxacin".
This graph shows the total number of publications written about "Ofloxacin" by people in this website by year, and whether "Ofloxacin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 | 1998 | 3 | 0 | 3 | 1999 | 1 | 0 | 1 | 2001 | 1 | 0 | 1 | 2003 | 2 | 0 | 2 | 2005 | 0 | 1 | 1 | 2006 | 1 | 0 | 1 | 2007 | 2 | 1 | 3 | 2008 | 2 | 0 | 2 | 2011 | 0 | 1 | 1 | 2013 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ofloxacin" by people in Profiles.
-
Woods JL, Scurlock AM, Hensel DJ. Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider. Pediatr Emerg Care. 2013 Jun; 29(6):720-5.
-
Hawkins S, Rausch CM, McCanta AC. Constrictive pericarditis secondary to infection with Mycoplasma pneumoniae. Curr Opin Pediatr. 2011 Feb; 23(1):126-9.
-
Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, Rozwadowski J, Mehler PS, Price CS. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med. 2008 Oct; 121(10):876-84.
-
Glasheen JJ, Prochazka AV. Further evidence of a clinically significant levofloxacin-warfarin interaction. South Med J. 2008 Jun; 101(6):660; author reply 660.
-
Page RL, Ferguson D, Cantu M. An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure. Cardiology. 2008; 110(2):112-5.
-
Glasheen JJ, Prochazka AV. The safety of levofloxacin in patients on warfarin. Am J Med. 2007 Apr; 120(4):e13; author reply e15-6.
-
Lee CKK, Boyle MP, Diener-West M, Brass-Ernst L, Noschese M, Zeitlin PL. Levofloxacin pharmacokinetics in adult cystic fibrosis. Chest. 2007 Mar; 131(3):796-802.
-
Kiser TH, Hoody DW, Obritsch MD, Wegzyn CO, Bauling PC, Fish DN. Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury. Antimicrob Agents Chemother. 2006 Jun; 50(6):1937-45.
-
Glasheen JJ, Fugit RV, Prochazka AV. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med. 2005 Jul; 20(7):653-6.
-
Fish DN. Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'. Expert Rev Anti Infect Ther. 2003 Oct; 1(3):371-87.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|